Segui
Roberto Ronca
Titolo
Citata da
Citata da
Anno
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
M Presta, P Dell’Era, S Mitola, E Moroni, R Ronca, M Rusnati
Cytokine & growth factor reviews 16 (2), 159-178, 2005
16432005
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
V Bronte, E Apolloni, A Cabrelle, R Ronca, P Serafini, P Zamboni, ...
Blood, The Journal of the American Society of Hematology 96 (12), 3838-3846, 2000
6792000
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis
R Giavazzi, B Sennino, D Coltrini, A Garofalo, R Dossi, R Ronca, ...
The American journal of pathology 162 (6), 1913-1926, 2003
2142003
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development
P Dell’Era, R Ronca, L Coco, S Nicoli, M Metra, M Presta
Circulation research 93 (5), 414-420, 2003
1892003
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis
M Presta, G Andrés, D Leali, P Dell’Era, R Ronca
European cytokine network 20 (2), 39-50, 2009
1862009
Tumor angiogenesis revisited: regulators and clinical implications
R Ronca, M Benkheil, S Mitola, S Struyf, S Liekens
Medicinal research reviews 37 (6), 1231-1274, 2017
1822017
Genetic vaccination with “self” tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
V Bronte, E Apolloni, R Ronca, P Zamboni, WW Overwijk, DR Surman, ...
Cancer Research 60 (2), 253-258, 2000
1682000
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
M Presta, P Chiodelli, A Giacomini, M Rusnati, R Ronca
Pharmacology & therapeutics 179, 171-187, 2017
1672017
Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapy
C Ebbinghaus, R Ronca, M Kaspar, D Grabulovski, A Berndt, H Kosmehl, ...
International journal of cancer 116 (2), 304-313, 2005
1432005
Heparin derivatives as angiogenesis inhibitors
M Presta, D Leali, H Stabile, R Ronca, M Camozzi, L Coco, E Moroni, ...
Current pharmaceutical design 9 (7), 553, 2003
1392003
Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy
R Ronca, A Giacomini, E Di Salle, D Coltrini, K Pagano, L Ragona, ...
Cancer cell 28 (2), 225-239, 2015
1152015
Blocking the FGF/FGFR system as a⿿ two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
A Giacomini, P Chiodelli, S Matarazzo, M Rusnati, M Presta, R Ronca
Pharmacological research 107, 172-185, 2016
932016
Long pentraxin 3: A novel multifaceted player in cancer
A Giacomini, GC Ghedini, M Presta, R Ronca
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (1), 53-63, 2018
912018
Future applications of FGF/FGFR inhibitors in cancer
GC Ghedini, R Ronca, M Presta, A Giacomini
Expert review of anticancer therapy 18 (9), 861-872, 2018
902018
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
R Ronca, A Giacomini, M Rusnati, M Presta
Expert opinion on therapeutic targets 19 (10), 1361-1377, 2015
872015
Long pentraxin-3 inhibits epithelial–mesenchymal transition in melanoma cells
R Ronca, E Di Salle, A Giacomini, D Leali, P Alessi, D Coltrini, C Ravelli, ...
Molecular cancer therapeutics 12 (12), 2760-2771, 2013
842013
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2
M Presta, E Foglio, R Ronca
Frontiers in immunology 9, 420510, 2018
772018
Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis
D Leali, A Inforzato, R Ronca, R Bianchi, M Belleri, D Coltrini, E Di Salle, ...
Arteriosclerosis, thrombosis, and vascular biology 32 (3), 696-703, 2012
762012
Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer
R Ronca, P Alessi, D Coltrini, E Di Salle, A Giacomini, D Leali, M Corsini, ...
The Journal of pathology 230 (2), 228-238, 2013
742013
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
F Roncato, F Rruga, E Porcù, E Casarin, R Ronca, F Maccarinelli, ...
Nature communications 9 (1), 4070, 2018
702018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20